News

GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...
As a result, a market for cheaper, off-brand versions of their active ingredients — semaglutide and tirzepatide — has ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
Our most-read articles explore “occlusion MI” versus STEMI, TAVI in asymptomatic AS, and highlights from recent conferences.
Compounded GLP-1s are no longer to be sold following the FDA announcement that the shortage of semaglutide and tirzepatide ended.
The medicines watchdog has issued an urgent warning about a deluge of social media advertisements for counterfeit weight-loss drugs.
HPRA concerned by promotions for ‘made in Ireland’ obesity medications wrongly claiming to be approved by charities, ...
Vivani Medical is developing GLP-1 subdermal implants that aim to provide a consistent therapeutic dose for six months, and ...
The HPRA warned that “dubious sites and social media posts” are using the official HPRA logo to falsely claim products are ...
As global shortages hit Ozempic and Wegovy, rivals like Eli Lilly gain ground, including in India’s growing market for ...
Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant ...
A LOVE Island star has hit out in a ‘fat jab’ rant as he showed off his ripped physique. Viewers first saw the fitness influencer enter the ITV2 villa back in 2019. Anton Danyluk, 30, ...